As shown in Figure 1, serum Angptl3 and 8 levels of patients with CH or SCH were significantly increased when compared with controls [Angptl3, 5.49 (5.11–5.88) vs. 4.94 (4.63–5.26), p = 0.026; 5.36 (5.03–5.69) vs. 4.94 (4.63–5.26) ng/ml, p = 0.035. Here, ANGPTL3 is linked to cyclic hematopoiesis.